Pancreatic Cancer Research

ResearcherRoswell Park Comprehensive Cancer CenterActive in the last 2 years

Katherine J. Crawford

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3513-3693; OpenAlex author ID A5020037276. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

  1. HNF1A is a novel BRD4 target and critical for BET-inhibitor response in pancreatic ductal adenocarcinoma First author DOI 10.1038/s42003-026-10685-z↗
  2. Targeting FGFR4 abrogates HNF1A-driven metastasis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12943-025-02408-5↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kennedy S. Humphrey · 2 shared papers, 2025–2026 · strength 0.51
  2. Erik S. Knudsen · 2 shared papers, 2025–2026 · strength 0.51
  3. Agnieszka Katarzyna Witkiewicz · 2 shared papers, 2025–2026 · strength 0.51
  4. Ethan V. Abel · 2 shared papers, 2025–2026 · strength 0.51
  5. Michael E. Feigin · 1 shared paper, 2025 · strength 0.23
  6. Vishnu Muthuraj Kumarasamy · 1 shared paper, 2025 · strength 0.23
  7. Karen M. Mann · 1 shared paper, 2025 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.